Publicaciones en las que colabora con CAROLINA MUGURUZA MILLAN (30)

2024

  1. Effects of cannabidiol in post-stroke mood disorders in neonatal rats

    Pediatric Research, Vol. 95, Núm. 7, pp. 1783-1790

  2. Exploring the reactivity of bicyclic α-iminophosphonates to access new imidazoline I2 receptor ligands

    Bioorganic Chemistry, Vol. 142

2023

  1. The Role of the Dopamine System in Post-Stroke Mood Disorders in Newborn Rats

    International Journal of Molecular Sciences, Vol. 24, Núm. 4

2022

  1. Glucocorticoid receptor dysregulation underlies 5-HT2AR-dependent synaptic and behavioral deficits in a mouse neurodevelopmental disorder model

    Journal of Biological Chemistry, Vol. 298, Núm. 11

  2. Glutamate, Glutamatergic Drugs and Schizophrenia

    Glutamate and Neuropsychiatric Disorders: Current and Emerging Treatments (Springer International Publishing), pp. 493-521

2021

  1. Differential brain ADRA2A and ADRA2C gene expression and epigenetic regulation in schizophrenia. Effect of antipsychotic drug treatment

    Translational Psychiatry, Vol. 11, Núm. 1

  2. Opposite alterations of 5­HT2A receptor brain density in subjects with schizophrenia: relevance of radiotracers pharmacological profile

    Translational Psychiatry, Vol. 11, Núm. 1

  3. Sex-dependent pharmacological profiles of the synthetic cannabinoid MMB-Fubinaca

    Addiction Biology, Vol. 26, Núm. 3

  4. Subcellular specificity of cannabinoid effects in striatonigral circuits

    Neuron, Vol. 109, Núm. 9, pp. 1513-1526.e11

  5. α2A- and α2C-adrenoceptor expression and functionality in postmortem prefrontal cortex of schizophrenia subjects

    European Neuropsychopharmacology, Vol. 52, pp. 3-11

2020

  1. Bicyclic α-Iminophosphonates as High Affinity Imidazoline I2 Receptor Ligands for Alzheimer's Disease

    Journal of Medicinal Chemistry, Vol. 63, Núm. 7, pp. 3610-3633

  2. Erratum: Bicyclic α-Iminophosphonates as High Affinity Imidazoline I2Receptor Ligands for Alzheimer's Disease (Journal of Medicinal Chemistry (2020) 63:7 (3610−3633) DOI: 10.1021/acs.jmedchem.9b02080)

    Journal of Medicinal Chemistry

  3. Long-term hippocampal interneuronopathy drives sex-dimorphic spatial memory impairment induced by prenatal THC exposure

    Neuropsychopharmacology, Vol. 45, Núm. 5, pp. 877-886

2019

  1. Endocannabinoid system imbalance in the postmortem prefrontal cortex of subjects with schizophrenia

    Journal of Psychopharmacology, Vol. 33, Núm. 9, pp. 1132-1140

  2. Serotonin 5-HT2A receptor expression and functionality in postmortem frontal cortex of subjects with schizophrenia: Selective biased agonism via Gαi1-proteins

    European Neuropsychopharmacology, Vol. 29, Núm. 12, pp. 1453-1463

2018

  1. Disfunción sináptica y alteraciones cognitivas inducidas por los antipsicóticos

    Mente y cerebro, Núm. 90, pp. 41-43

  2. The endocannabinoid system in mental disorders: Evidence from human brain studies

    Biochemical Pharmacology, Vol. 157, pp. 97-107

2017

  1. Antipsychotic-induced Hdac2 transcription via NF-ΰ B leads to synaptic and cognitive side effects

    Nature Neuroscience, Vol. 20, Núm. 9, pp. 1247-1259

  2. Thiophene/thiazole-benzene replacement on guanidine derivatives targeting α2-Adrenoceptors

    European Journal of Medicinal Chemistry, Vol. 138, pp. 38-50

2016

  1. Group II metabotropic glutamate receptors as targets for novel antipsychotic drugs

    Frontiers in Pharmacology, Vol. 7, Núm. MAY